Please rate this video

IMW 2019 | Serum BCMA: a new prognostic marker for PFS in myeloma

Please rate this video

James Berenson

James Berenson, MD, from The Institute for Myeloma & Bone Cancer Research, West Hollywood, CA, speaks at the International Myeloma Workshop (IMW) 2019, held in Boston, MA, about monitoring serum BCMA levels to indicate prognosis in multiple myeloma.

Share this video  

Sign-up for our Newsletter!

Keep up to date with all the latest news with our monthly newsletter